Wednesday, February 12, 2014

Benefits of Letrozole during post cycle therapy


When it comes to reducing or eliminating estrogenic side effects such as oily skin, acne, gynecomastia, and bloating, there are not many products as beneficial as the non-steroidal aromatase inhibitor, Letrozole. Also known as Femara, it is believed to be one of the most potent drugs for stimulating metabolic rate of the body and promoting fat burning.

Medically indicated for patients with hormonally responsive breast cancer after surgery, Letrozole has the molecular weight of 285.31 g/mol at the base and is highly effective for reducing the levels of LDL (bad) cholesterol and promoting the level of spermatogenesis in male patients suffering from non-obstructive azoospermia. This antiestrogen is also useful in treating endometriosis.

The third-generation selective oral aromatase inhibitor is rated by sport and gym coaches as one of the best post cycle therapy drugs that can even promote growth hormone, cortisol, SHBG, hepatic production of binding proteins, HDL, and growth and development of sexual characteristics. One of the biggest advantages associated with the use of Letrozole is that it is very effective for slowing or reversing the growth of certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause or preventing the cancer from making a return.

Letrozole use is not recommended for pregnant and breastfeeding women and suffering with prostate, breast, or testicular cancer or treated for high blood pressure, liver damage, stroke, and kidney damage. When overdosed or of a low grade, Letrozole abuse can lead to side effects like hot flushes, night sweats, vomiting, bone pain, loss of appetite, headache, stomach pain, cough, and breast pain.